Ultraviolet recall due to cytarabine chemotherapy for acute myeloid leukaemia | BMJ Case Reports

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Global health

Authors

About

Help
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Citation Tools

Images in…

Ultraviolet recall due to cytarabine chemotherapy for acute myeloid leukaemia

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Kuo DJ, Spies JM, Le Floch N, et al

Ultraviolet recall due to cytarabine chemotherapy for acute myeloid leukaemia

BMJ Case Reports CP 2021;14:e246596.